Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entyvio IV for chronic or recurrent pouchitis
2015-003472-78Phase 4Completed
- Sponsor
- Takeda
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pouchitis comparing Vedolizumab IV with Placebo (2 arms). Primary endpoint: Clinically relevant remission at Week 14. Started Jun 2016; status: completed.
02
Drugs
vedolizumab
03
Conditions
pouchitis
Beyond the preview
Go deeper on 2015-003472-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003472-78.